Business Context and Reporting Period
This Form 8-K was filed by TradeUP Acquisition Corp., not Estrella Immunopharma, Inc. The report date is April 21, 2023, concerning an event on April 19, 2023. TradeUP is a special purpose acquisition company with securities listed on Nasdaq.
Material Event and Listing Status
On April 19, 2023, TradeUP received a written deficiency notice from Nasdaq stating that it was not in compliance with Nasdaq Listing Rule 5550(a)(3), the Minimum Public Holders Rule. The rule requires at least 300 public holders for continued listing on the Nasdaq Capital Market.
- The notice is a deficiency notification and does not represent an imminent delisting.
- The notice had no immediate effect on the listing or trading of the company’s securities.
- The company has 45 calendar days to submit a plan to regain compliance.
- If Nasdaq accepts the plan, it may grant an extension of up to 180 calendar days from the notice date to demonstrate compliance.
- If Nasdaq rejects the plan, the company may appeal to a Nasdaq Hearings Panel.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics. It is limited to a Nasdaq listing-compliance matter.
Guidance, Outlook, Risks, and Unusual Items
Management stated that it intends to submit a compliance plan within the required timeframe. The principal risk is that the company may be unable to regain compliance with the Minimum Public Holders Rule or otherwise satisfy Nasdaq’s continued-listing standards, which could ultimately result in delisting proceedings.
The filing’s forward-looking statements are subject to substantial risks and uncertainties, and the company disclaims any obligation to update them.
Most Important Facts to Verify
- Confirm that the filing entity is TradeUP Acquisition Corp.; the supplied metadata identifies Estrella Immunopharma, Inc., which does not match the filing text.
- Verify the number of public holders and the company’s calculation under Nasdaq Rule 5550(a)(3).
- Confirm whether TradeUP submitted its compliance plan within the 45-day deadline.
- Check whether Nasdaq accepted the plan, granted an extension, or initiated further delisting proceedings.
- Review subsequent SEC filings and Nasdaq notices for the ultimate listing outcome.